The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
Abstract
The power of placebos has long been recognized for improving numerous medical conditions such as Parkinson's disease (PD). Little is known, however, about the mechanism underlying the placebo effect. Using the ability of endogenous dopamine to compete for [ 11 C]raclopride binding as measured by positron emission tomography, we provide in vivo evidence for substantial release of endogenous dopamine in the striatum of PD patients in response to placebo. Our findings indicate that the placebo effect in PD is powerful and is mediated through activation of the damaged nigrostriatal dopamine system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Beecher, H. K. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960340022006 · Cited by 1,842
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Ikemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Evidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279
Biostatistics: A Methodology for the Health Sciences.
D'Agostino, R. B., Fisher, L. D., & van Belle, G. (1995) · Journal of the American Statistical Association · doi:10.2307/2291095 · Cited by 957
Cited by
Habits, Rituals, and the Evaluative Brain
Graybiel, A. M. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112851 · Cited by 1,697
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
The neuroscience of placebo effects: connecting context, learning and health
Wager, T. D., & Atlas, L. Y. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3976 · Cited by 844
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779
Neurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
The dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.34 · Cited by 637
When words are painful: unraveling the mechanisms of the nocebo effect
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.020 · Cited by 636
“However, whereas in the first case some neurobiological mechanisms have been uncovered, such as dopamine release in the striatum (de la Fuente-Fernandez et al., 2001) and altered firing pattern in subthalamic nucleus neurons (Benedetti et al., 2004), in the second case only behavioral/clinical…”
BackgroundKaptchuk, T. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00011 · Cited by 616
Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
Tracey, I. (2010) · Nature Medicine · doi:10.1038/nm.2229 · Cited by 553
“But is there a role for NAc dopamine in placebo effects? Basal ganglia dopamine release has been reported in the placebo arm of a clinical trial in people with Parkinson's diseas”
BackgroundOvert versus covert treatment for pain, anxiety, and Parkinson's disease
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00908-1 · Cited by 552
Linde, K., Witt, C. M., Streng, A., Weidenhammer, W., Wagenpfeil, S., Brinkhaus, B., Willich, S. N., & Melchart, D. (2007) · Pain · doi:10.1016/j.pain.2006.12.006 · Cited by 551
Neural regulation of immunity: molecular mechanisms and clinical translation
Pavlov, V. A., & Tracey, K. J. (2017) · Nature Neuroscience · doi:10.1038/nn.4477 · Cited by 532
New Insights into the Placebo and Nocebo Responses
Enck, P., Benedetti, F., & Schedlowski, M. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.030 · Cited by 531
Placebo and the New Physiology of the Doctor-Patient Relationship
Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492
Hartogsohn, I. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677852 · Cited by 483
Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., & Young, B. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.2.0216 · Cited by 475
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Goetz, C. G. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008862 · Cited by 470
Placebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465
Individual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452
How Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446
How prior experience shapes placebo analgesia
Colloca, L., & Benedetti, F. (2006) · Pain · doi:10.1016/j.pain.2006.04.005 · Cited by 443
Petrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.023 · Cited by 437
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419
Cho, S. S., & Strafella, A. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006725 · Cited by 415
de la Fuente-Fernandez, R. (2004) · Brain · doi:10.1093/brain/awh290 · Cited by 402
Self-citationExpectancy and belief modulate the neuronal substrates of pain treated by acupuncture
Pariente, J., White, P., Frackowiak, R. S. J., & Lewith, G. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.016 · Cited by 386
Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments
Benedetti, F. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094711 · Cited by 385
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease
Barker, R. A., Barrett, J., Mason, S. L., & Björklund, A. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70295-8 · Cited by 365
Consensus paper: Combining transcranial stimulation with neuroimaging
Siebner, H. R., Bergmann, T. O., Bestmann, S., Massimini, M., Johansen-Berg, H., Mochizuki, H., Bohning, D. E., Boorman, E. D., Groppa, S., Miniussi, C., et al. (2009) · Brain Stimulation · doi:10.1016/j.brs.2008.11.002 · Cited by 356
Sterling, P. (2004) · Allostasis, Homeostasis, and the Costs of Physiological Adaptation · doi:10.1017/cbo9781316257081.004 · Cited by 353
“This hypothesis is now supported by PET which shows placebo and opioid analgesia activating the same brain regions (Petrovic et al., 2002).”
BackgroundNocebo hyperalgesia: how anxiety is turned into pain
Colloca, L., & Benedetti, F. (2007) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282b972fb · Cited by 350
Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., & Asteggiano, G. (2006) · Pain · doi:10.1016/j.pain.2005.12.016 · Cited by 347
Smoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
Peet, M., & Horrobin, D. F. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00048-6 · Cited by 329
Wager, T. D., Atlas, L. Y., Leotti, L. A., & Rilling, J. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3420-10.2011 · Cited by 328
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
How placebo responses are formed: a learning perspective
Colloca, L., & Miller, F. G. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0398 · Cited by 323
Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
Lidstone, S. C., Schulzer, M., Dinelle, K., Mak, E., Sossi, V., Ruth, T. J., de la Fuente-Fernández, R., Phillips, A. G., & Stoessl, A. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.88 · Cited by 323
Self-citationDopamine release in human ventral striatum and expectation of reward
de la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00130-4 · Cited by 319
Self-citationPlacebo Effects: From the Neurobiological Paradigm to Translational Implications
Benedetti, F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.023 · Cited by 317
Petrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309
Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., Bergamasco, B., & Lopiano, L. (2004) · Nature Neuroscience · doi:10.1038/nn1250 · Cited by 309
Boileau, I., Dagher, A., Leyton, M., Gunn, R. N., Baker, G. B., Diksic, M., & Benkelfat, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1386 · Cited by 305
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., Telang, F., Vaska, P., Ding, Y.-S., Wong, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11461.2003 · Cited by 302
“For example, this was documented in a study of Parkinson’s disease when a placebo resulted in DA increases that were equivalent to those induced by a DA agonist drug ( de la Fuente-Fernandez et al., 2001 ).”
ResultHow the number of learning trials affects placebo and nocebo responses
Colloca, L., Petrovic, P., Wager, T. D., Ingvar, M., & Benedetti, F. (2010) · Pain · doi:10.1016/j.pain.2010.08.007 · Cited by 300
Minimal clinically important change on the unified Parkinson's disease rating scale
Schrag, A., Sampaio, C., Counsell, N., & Poewe, W. (2006) · Movement Disorders · doi:10.1002/mds.20914 · Cited by 297
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011) · Nature Medicine · doi:10.1038/nm.2435 · Cited by 289
The neural correlates of placebo effects: a disruption account
Lieberman, M. D., Jarcho, J. M., Berman, S., Naliboff, B. D., Suyenobu, B. Y., Mandelkern, M., & Mayer, E. A. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.037 · Cited by 289
Meaning, medicine, and the "placebo effect"
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6449 · Cited by 289
Neurobiological Mechanisms of Placebo Responses
Zubieta, J., & Stohler, C. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04424.x · Cited by 277
McRae, C., Cherin, E., Yamazaki, T. G., Diem, G., Vo, A. H., Russell, D., Ellgring, J. H., Fahn, S., Greene, P., Dillon, S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.412 · Cited by 278
Activation of the reward system boosts innate and adaptive immunity
Ben-Shaanan, T. L., Azulay-Debby, H., Dubovik, T., Starosvetsky, E., Korin, B., Schiller, M., Green, N. L., Admon, Y., Hakim, F., Shen-Orr, S. S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4133 · Cited by 272
The Placebo Effect in Pain Therapies
Colloca, L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021542 · Cited by 270
Genetics and the placebo effect: the placebome
Hall, K. T., Loscalzo, J., & Kaptchuk, T. J. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.009 · Cited by 266
Wager, T. D., van Ast, V. A., Hughes, B. L., Davidson, M. L., Lindquist, M. A., & Ochsner, K. N. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.044 · Cited by 264
Rief, W., Shedden-Mora, M. C., Laferton, J. A. C., Auer, C., Petrie, K. J., Salzmann, S., Schedlowski, M., & Moosdorf, R. (2017) · BMC Medicine · doi:10.1186/s12916-016-0767-3 · Cited by 261
“, opioid pathways in placebo analgesia [35], dopaminergic pathways of placebo effects in Parkinson’s disease [36], or neural plasticity effects of context factors in psychopharmacological treatments [37].”
BackgroundDopamine dysregulation syndrome in Parkinson's disease
Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257
The Placebo Effect: Illness and Interpersonal Healing
Miller, F. G., Colloca, L., & Kaptchuk, T. J. (2009) · Perspectives in Biology and Medicine · doi:10.1353/pbm.0.0115 · Cited by 254
Goetz, C. G., Wuu, J., McDermott, M. P., Adler, C. H., Fahn, S., Freed, C. R., Hauser, R. A., Olanow, W. C., Shoulson, I., Tandon, P. K., et al. (2008) · Movement Disorders · doi:10.1002/mds.21894 · Cited by 253
Placebo effects: clinical aspects and neurobiology
Oken, B. S. (2008) · Brain · doi:10.1093/brain/awn116 · Cited by 237
Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-08.2008 · Cited by 210
Schweinhardt, P., Seminowicz, D. A., Jaeger, E., Duncan, G. H., & Bushnell, M. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5634-08.2009 · Cited by 210
“This supports a recent theory that conceptualizes the anticipation of clinical benefit, crucial for the placebo response, as a special case of reward anticipation (de la Fuente-Fernández et al., 2001).”
BackgroundThe placebo effect in neurological disorders
de la Fuente-Fernández, R., Schulzer, M., & Stoessl, A. J. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00038-8 · Cited by 187
Self-citationHow the doctor's words affect the patient's brain
Benedetti, F. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702238051 · Cited by 173
“…together, indicate that a placebo procedure with its verbal context is capable of inducing the release of endogenous substances in very specific brain regions, such as the brain stem in analgesia (Petrovic et al., 2002) or the striatum in Parkinson’s disease (de la Fuente-Fernández et al., 2001).”
BackgroundNeural bases of conditioned placebo analgesia
Lui, F., Colloca, L., Duzzi, D., Anchisi, D., Benedetti, F., & Porro, C. A. (2010) · Pain · doi:10.1016/j.pain.2010.09.021 · Cited by 149
“Evidence from different clinical and experimental models, such as Parkinson’s disease [4,12], hormone secretion [6], immune responses and emotion [33], suggests the crucial role of past experience for generating placebo effects.”
BackgroundThe placebo response: how words and rituals change the patient's brain
Benedetti, F., & Amanzio, M. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.04.034 · Cited by 132
“As the patients who experienced symptomatic benefit released more dopamine in the dorsal striatum than those who did not, the degree of placebo-induced dopamine release in the dorsal striatum seems to be related to the degree of perceived improvement by the patient [28].”
BackgroundMethodMotor learning benefits of self-controlled practice in persons with Parkinson's disease
Chiviacowsky, S., Wulf, G., Lewthwaite, R., & Campos, T. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2011.12.003 · Cited by 127
Conditioned and sensitized responses to stimulant drugs in humans
Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127
Expectation of caffeine induces dopaminergic responses in humans
Kaasinen, V., Aalto, S., Någren, K., & Rinne, J. O. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03310.x · Cited by 118
Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride
Slifstein, M., Kegeles, L. S., Xu, X., Thompson, J. L., Urban, N., Castrillon, J., Hackett, E., Bae, S. ‐., Laruelle, M., & Abi‐Dargham, A. (2010) · Synapse · doi:10.1002/syn.20734 · Cited by 115
Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110
“…the high affinity state, which may well be abnormal in disorders such as schizophrenia (Farde et al., 1987; Laruelle et al., 1996), Parkinson’s disease (de La Fuente-Fernandez et al., 2001; Tedroff et al., 1996), bipolar disorder, and unipolar depression (Anand et al., 2000; Parsey et al., 2001).”
BackgroundBergasa, N. V., McGee, M., Ginsburg, I. H., & Engler, D. (2006) · Hepatology · doi:10.1002/hep.21370 · Cited by 107
The placebo response in functional bowel disorders: perspectives and putative mechanisms
Enck, P., & Klosterhalfen, S. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00676.x · Cited by 101
Sun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
The placebo-reward hypothesis: dopamine and the placebo effect
de la Fuente-Fernández, R. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70785-0 · Cited by 95
Mechanisms of the placebo response
Benedetti, F., & Amanzio, M. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.01.006 · Cited by 93
Salience Network Functional Connectivity Predicts Placebo Effects in Major Depression
Sikora, M., Heffernan, J., Avery, E. T., Mickey, B. J., Zubieta, J.-K., & Peciña, M. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.10.002 · Cited by 85
Mind matters: placebo enhances reward learning in Parkinson's disease
Schmidt, L., Braun, E. K., Wager, T. D., & Shohamy, D. (2014) · Nature Neuroscience · doi:10.1038/nn.3842 · Cited by 84
Mindfulness Training among Individuals with Parkinson’s Disease: Neurobehavioral Effects
Pickut, B., Vanneste, S., Hirsch, M. A., Van Hecke, W., Kerckhofs, E., Mariën, P., Parizel, P. M., Crosiers, D., & Cras, P. (2015) · Parkinson's Disease · doi:10.1155/2015/816404 · Cited by 80
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00336-2 · Cited by 79
Placebo-Induced Changes in Excitatory and Inhibitory Corticospinal Circuits during Motor Performance
Fiorio, M., Emadi Andani, M., Marotta, A., Classen, J., & Tinazzi, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3931-13.2014 · Cited by 70
Placebo responses in patients with gastrointestinal disorders
Musial, F. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i25.3425 · Cited by 70
Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67
Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111414090 · Cited by 63
Webb, C. A., Kertz, S. J., Bigda-Peyton, J. S., & Björgvinsson, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.016 · Cited by 55
Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm
Wrobel, N., Wiech, K., Forkmann, K., Ritter, C., & Bingel, U. (2014) · Cortex · doi:10.1016/j.cortex.2014.02.023 · Cited by 45
Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis
Curie, A., Yang, K., Kirsch, I., Gollub, R. L., des Portes, V., Kaptchuk, T. J., & Jensen, K. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133316 · Cited by 43
Webb, C. A., Beard, C., Auerbach, R. P., Menninger, E., & Björgvinsson, T. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.015 · Cited by 38
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning
Frisaldi, E., Carlino, E., Zibetti, M., Barbiani, D., Dematteis, F., Lanotte, M., Lopiano, L., & Benedetti, F. (2017) · Movement Disorders · doi:10.1002/mds.27142 · Cited by 35
Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0193-2 · Cited by 18
Wolpe, N., Nombela, C., & Rowe, J. B. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01514 · Cited by 18
Ashor, A. W. (2011) · Annals Of Neurosciences · doi:10.5214/ans.0972.7531.1118403 · Cited by 12
Promising therapeutic agents for the treatment of Parkinson’s disease
Majláth, Z., Török, N., Toldi, J., & Vécsei, L. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1164687 · Cited by 7
Metadata
- Authors
- de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J.
- Venue
- Science
- Published
- 2001-08-10
- Volume
- 293
- Issue
- 5532
- Pages
- 1164-1166
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2125295858
- Cited by
- 991
- References
- 25
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.